Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oxaspiro Chiral Phosphoric Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113150031A discloses a novel oxaspiro chiral phosphoric acid enabling >97% ee in asymmetric synthesis. Reliable supplier for high-purity pharmaceutical intermediates.